Trial Profile
A Randomized, Open-label, Six-sequence, Three-period, Multiple Dosing Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2015
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary) ; Atorvastatin
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 25 Jul 2015 Status changed from not yet recruiting to completed as per ClinicalTrials.gov record.
- 28 Mar 2015 New trial record